+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology; Type; Indication; End User, and Country and Country

  • ID: 5204960
  • Report
  • October 2020
  • Region: Europe
  • 177 pages
  • The Insight Partners
UP TO OFF
until Jan 31st 2021

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Aduro Biotech Inc
  • AstraZeneca
  • Bristol-Myers Squibb
  • GlaxoSmithKline plc.
  • MaxiVAX
  • Moderna, Inc.
Cancer Vaccines Market for Dendritic Cells Cancer Vaccines Segment to Grow at Fastest CAGR during Forecast Period

According to the new market research study on “Cancer Vaccines Market to 2027 - Europe Analysis and Forecast - by Technology, Type, Indication, and End Use” the market is expected to reach to reach US$4,680.79 million by 2027; it is expected to grow at a CAGR of 16.8% during the forecast period. The report highlights trends prevailing in the Europe Cancer Vaccines Market and the drivers and restraints pertaining to the market growth.

Based on technology, the Cancer Vaccines market is segmented into in dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, viral vector cancer vaccines. The in recombinant cancer vaccines segment held the largest share of the market in 2019. Moreover, recombinant cancer vaccines is estimated grow at the highest CAGR in the market during the forecast period.

Market growth in Europe Cancer Vaccines is mainly due to factors such as increasing prevalence of cancer and rising government initiatives to prevent cancer. However, challenges such as costly costs in the cancer vaccine industry restrict the growth of the market.

AstraZeneca, GlaxoSmithKline plc., Aduro Biotech Inc, Pfizer Inc., Sanofi, Bristol-Myers Squibb, Moderna, Inc., OncBioMune Pharmaceuticals Inc., MaxiVAX, Nouscom are among the leading companies operating in the Cancer Vaccines Market.

The report segments Europe Cancer Vaccines market as follows:

By Technology
  • Dendritic Cells Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector Cancer VaccinesBy Type
  • Preventive Cancer Vaccines
  • Therapeutic Cancer VaccineBy Indication
  • Cervical Cancer
  • Prostate Cancer
  • Other IndicationsBy End-Use
  • Pediatrics
  • AdultsBy Country
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
Reasons to Buy
  • To understand the Europe cancer vaccines market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe cancer vaccines market
  • Efficiently plan M&A and partnership deals in the Europe cancer vaccines market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the Europe cancer vaccines market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aduro Biotech Inc
  • AstraZeneca
  • Bristol-Myers Squibb
  • GlaxoSmithKline plc.
  • MaxiVAX
  • Moderna, Inc.
1. Introduction
1.1. Scope Of The Study
1.2. Research Report Guidance
1.3. Market Segmentation
1.3.1 Cancer Vaccines Market - By Technology
1.3.2 Cancer Vaccines Market - By Type
1.3.3 Cancer Vaccines Market - By Indication
1.3.4 Cancer Vaccines Market - By End User
1.3.5 Cancer Vaccines Market - By Country

2. Key Takeaways

3. Research Methodology

4. Cancer Vaccines Market Landscape
4.1. Overview
4.2. Pest Analysis
4.2.1 Europe - Pest Analysis
4.3. Expert Opinions

5. Cancer Vaccines Market - Key Market Dynamics
5.1. Key Market Drivers
5.2. Key Market Restraints
5.3. Key Market Opportunities
5.4. Future Trends
5.5. Impact Analysis Of Drivers And Restraints

6. Cancer Vaccines Market - Europe Market Analysis
6.1. Cancer Vaccines - Europe Market Overview
6.2. Cancer Vaccines - Europe Market And Forecast To 2027
6.3. Market Positioning/Market Share

7. Cancer Vaccines Market - Revenue And Forecasts To 2027 - Technology
7.1. Overview
7.2. Technology Market Forecasts And Analysis
7.3. Dendritic Cells Cancer Vaccines
7.3.1. Overview
7.3.2. Dendritic Cells Cancer Vaccines Market Forecast And Analysis
7.4. Recombinant Cancer Vaccines
7.4.1. Overview
7.4.2. Recombinant Cancer Vaccines Market Forecast And Analysis
7.5. Antigen Cancer Vaccines
7.5.1. Overview
7.5.2. Antigen Cancer Vaccines Market Forecast And Analysis
7.6. Whole Cell Cancer Vaccines
7.6.1. Overview
7.6.2. Whole Cell Cancer Vaccines Market Forecast And Analysis
7.7. Viral Vector Cancer Vaccines
7.7.1. Overview
7.7.2. Viral Vector Cancer Vaccines Market Forecast And Analysis

8. Cancer Vaccines Market - Revenue And Forecasts To 2027 - Type
8.1. Overview
8.2. Type Market Forecasts And Analysis
8.3. Preventive Cancer Vaccines
8.3.1. Overview
8.3.2. Preventive Cancer Vaccines Market Forecast And Analysis
8.4. Therapeutic Cancer Vaccines
8.4.1. Overview
8.4.2. Therapeutic Cancer Vaccines Market Forecast And Analysis

9. Cancer Vaccines Market - Revenue And Forecasts To 2027 - Indication
9.1. Overview
9.2. Indication Market Forecasts And Analysis
9.3. Cervical Cancer
9.3.1. Overview
9.3.2. Cervical Cancer Market Forecast And Analysis
9.4. Prostate Cancer
9.4.1. Overview
9.4.2. Prostate Cancer Market Forecast And Analysis
9.5. Other Indications
9.5.1. Overview
9.5.2. Other Indications Market Forecast And Analysis

10. Cancer Vaccines Market - Revenue And Forecasts To 2027 - End User
10.1. Overview
10.2. End User Market Forecasts And Analysis
10.3. Pediatrics
10.3.1. Overview
10.3.2. Pediatrics Market Forecast And Analysis
10.4. Adults
10.4.1. Overview
10.4.2. Adults Market Forecast And Analysis

11. Cancer Vaccines Market Revenue And Forecasts To 2027 - Country Analysis
11.1 Europe Cancer Vaccines Market Overview
11.2 Europe Cancer Vaccines Market Forecasts And Analysis
11.3 Europe Cancer Vaccines Market Forecasts And Analysis - By Countries
11.3.1 Germany Cancer Vaccines Market
11.3.1.1 Germany Cancer Vaccines Market By Technology
11.3.1.2 Germany Cancer Vaccines Market By Type
11.3.1.3 Germany Cancer Vaccines Market By Indication
11.3.1.4 Germany Cancer Vaccines Market By End User
11.3.2 France Cancer Vaccines Market
11.3.2.1 France Cancer Vaccines Market By Technology
11.3.2.2 France Cancer Vaccines Market By Type
11.3.2.3 France Cancer Vaccines Market By Indication
11.3.2.4 France Cancer Vaccines Market By End User
11.3.3 Italy Cancer Vaccines Market
11.3.3.1 Italy Cancer Vaccines Market By Technology
11.3.3.2 Italy Cancer Vaccines Market By Type
11.3.3.3 Italy Cancer Vaccines Market By Indication
11.3.3.4 Italy Cancer Vaccines Market By End User
11.3.4 Spain Cancer Vaccines Market
11.3.4.1 Spain Cancer Vaccines Market By Technology
11.3.4.2 Spain Cancer Vaccines Market By Type
11.3.4.3 Spain Cancer Vaccines Market By Indication
11.3.4.4 Spain Cancer Vaccines Market By End User
11.3.5 United Kingdom Cancer Vaccines Market
11.3.5.1 United Kingdom Cancer Vaccines Market By Technology
11.3.5.2 United Kingdom Cancer Vaccines Market By Type
11.3.5.3 United Kingdom Cancer Vaccines Market By Indication
11.3.5.4 United Kingdom Cancer Vaccines Market By End User

12. Impact Of Covid-19 Pandemic On Global Cancer Vaccines Market
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Rest Of The World

13. Industry Landscape
13.1. Mergers And Acquisitions
13.2. Agreements, Collaborations And Joint Ventures
13.3. New Product Launches
13.4. Expansions And Other Strategic Developments

14. Cancer Vaccines Market, Key Company Profiles
14.1. Astrazeneca
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products And Services
14.1.4. Financial Overview
14.1.5. Swot Analysis
14.1.6. Key Developments
14.2. Glaxosmithkline Plc.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products And Services
14.2.4. Financial Overview
14.2.5. Swot Analysis
14.2.6. Key Developments
14.3. Aduro Biotech Inc
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products And Services
14.3.4. Financial Overview
14.3.5. Swot Analysis
14.3.6. Key Developments
14.4. Pfizer Inc.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products And Services
14.4.4. Financial Overview
14.4.5. Swot Analysis
14.4.6. Key Developments
14.5. Sanofi
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products And Services
14.5.4. Financial Overview
14.5.5. Swot Analysis
14.5.6. Key Developments
14.6. Bristol-Myers Squibb
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products And Services
14.6.4. Financial Overview
14.6.5. Swot Analysis
14.6.6. Key Developments
14.7. Moderna, Inc.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products And Services
14.7.4. Financial Overview
14.7.5. Swot Analysis
14.7.6. Key Developments
14.8. Oncbiomune Pharmaceuticals Inc.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products And Services
14.8.4. Financial Overview
14.8.5. Swot Analysis
14.8.6. Key Developments
14.9. Maxivax
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products And Services
14.9.4. Financial Overview
14.9.5. Swot Analysis
14.9.6. Key Developments
14.10. Nouscom
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products And Services
14.10.4. Financial Overview
14.10.5. Swot Analysis
14.10.6. Key Developments

15. Appendix
15.1. About the Publisher
15.2. Glossary Of Terms


List of Tables
Table 1. Europe Cancer Vaccines Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 2. Europe Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 3. Europe Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 4. Europe Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 5. Incidence, Mortality and Prevalence by cancer site, 2018, Germany
Table 6. Germany Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 7. Germany Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 8. Germany Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 9. Germany Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 10. UK Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 11. UK Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 12. UK Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 13. UK Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 14. Incidence, Mortality and Prevalence by cancer site, 2018, France
Table 15. France Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 16. France Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 17. France Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 18. France Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 19. Incidence, Mortality and Prevalence by cancer site, 2018, Spain
Table 20. Spain Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 21. Spain Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 22. Spain Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 23. Spain Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 24. Incidence, Mortality and Prevalence by cancer site, 2018, Italy
Table 25. Italy Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 26. Italy Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 27. Italy Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 28. Italy Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 29. Organic Developments Done By Companies
Table 30. Inorganic Developments Done By Companies
Table 31. Glossary of Terms, Cancer Vaccines Market

List of Figures
Figure 1. Cancer Vaccines Market Segmentation
Figure 2. Cancer Vaccines Segmentation - By Region
Figure 3. Europe Cancer Vaccines Market Overview
Figure 4. In Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market in 2019
Figure 5. Cancer Vaccines Market in US to Show Remarkable Growth During Forecast Period
Figure 7. Europe PEST Analysis
Figure 8. Cancer Statistics, 2020
Figure 9. Cancer Vaccines Market Impact Analysis of Driver and Restraints
Figure 10. Europe Cancer Vaccines Market - Revenue Forecast And Analysis - 2019-2027
Figure 11. Cancer Vaccines market Share, by Technology, 2019 and 2027 (%)
Figure 12. Dendritic Cells Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Recombinant Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Antigen Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Whole Cell Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Viral Vector Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
Figure 18. Preventive Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Therapeutic Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
Figure 21. Cervical Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Prostate Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Other Indications: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
Figure 25. Pediatrics: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Adults: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Europe: Cancer Vaccines Market, by Key Country - Revenue (2019) (USD Million)
Figure 28. Europe Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 29. Europe: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
Figure 30. Germany: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 31. UK: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 32. France: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 33. Spain: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. Italy: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 36. Growth Strategies Done by the Companies in the Market, (%)
Note: Product cover images may vary from those shown
  • AstraZeneca
  • GlaxoSmithKline plc.
  • Aduro Biotech Inc
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb
  • Moderna, Inc.
  • OncBioMune Pharmaceuticals Inc.
  • MaxiVAX
  • Nouscom
Note: Product cover images may vary from those shown
Adroll
adroll